Skip to main content
. 2022 Apr 12;14(4):e24069. doi: 10.7759/cureus.24069

Table 1. Baseline demographics and characteristics after propensity score matching.

Cohort 1: Ischemic stroke diagnosis with obesity and subsequent decompressive hemicraniectomy procedure. Cohort 2: Ischemic stroke diagnosis without obesity and subsequent decompressive hemicraniectomy procedure.

ICD-10: International Classification of Diseases, Tenth Revision; CPT: Current Procedural Terminology.

    Before matching After matching
Codes (ICD-10, medication, or CPT) Diagnosis Cohort 1, n (%) Cohort 2, n (%) Std. diff. Cohort 1, n (%) Cohort 2, n (%) Std. diff.
AI Age at index 55.41 (100.000) 56.26 (100.000) - 53.79 (100.000) 53.69 (100.000) -
M Male 920 (48.884) 3230 (59.605) 0.2165 337 (52.167) 327 (50.619) 0.030975
F Female 962 (51.116) 2189 (40.395) 0.2165 309 (47.833) 319 (49.381) 0.030975
2106-3 White 1303 (69.235) 3824 (70.567) 0.0290 451 (69.814) 463 (71.672) 0.04084
2054-5 Black or African American 409 (21.732) 910 (16.793) 0.1255 139 (21.517) 130 (20.124) 0.034318
2131-1 Unspecified race 142 (7.545) 564 (10.408) 0.1003 46 (7.121) 39 (6.037) 0.043719
2028-9 Asian 20 (1.063) 101 (1.864) 0.0668 10 (1.548) 13 (2.012) 0.035126
I10-I16 Hypertensive diseases 1476 (78.427) 3268 (60.306) 0.4009 418 (64.706) 402 (62.229) 0.051454
E78 Disorders of lipoprotein metabolism and other lipidemias 982 (52.179) 1828 (33.733) 0.3793 244 (37.771) 237 (36.687) 0.022417
E08-E13 Diabetes mellitus, type 1 and type 2 786 (41.764) 1097 (20.244) 0.4784 181 (28.019) 165 (25.542) 0.055955
R53 Malaise and fatigue 559 (29.702) 1121 (20.686) 0.2088 149 (23.065) 119 (18.421) 0.114722
F17 Nicotine dependence 468 (24.867) 1127 (20.797) 0.0971 123 (19.040) 104 (16.099) 0.077343
I20-I25 Ischemic heart diseases 525 (27.896) 1090 (20.114) 0.1829 120 (18.576) 108 (16.718) 0.048742
R13 Aphagia and dysphagia 550 (29.224) 1295 (23.897) 0.1208 115 (17.802) 108 (16.718) 0.028677
J40-J47 Chronic lower respiratory diseases 481 (25.558) 825 (15.224) 0.2586 107 (16.563) 105 (16.254) 0.00836
N17-N19 Acute kidney failure and chronic kidney disease 501 (26.621) 926 (17.088) 0.2322 95 (14.706) 86 (13.313) 0.040148
R40 Somnolence, stupor, and coma 459 (24.389) 1214 (22.403) 0.0469 82 (12.693) 70 (10.836) 0.057679
I48 Atrial fibrillation and flutter 366 (19.447) 785 (14.486) 0.1325 76 (11.765) 63 (9.752) 0.06498
I50 Heart failure 383 (20.351) 610 (11.257) 0.2513 71 (10.991) 67 (10.372) 0.020048
Z87.891 Personal history of nicotine dependence 348 (18.491) 587 (10.832) 0.2178 65 (10.062) 59 (9.133) 0.031536
R63 Symptoms and signs concerning food and fluid intake 177 (9.405) 343 (6.330) 0.1144 43 (6.656) 42 (6.502) 0.006244
I73 Other peripheral vascular diseases 136 (7.226) 232 (4.281) 0.1267 35 (5.418) 27 (4.180) 0.057963
F10.1 Alcohol abuse 88 (4.676) 310 (5.721) 0.0471 20 (3.096) 16 (2.477) 0.037629
F10.2 Alcohol dependence 65 (3.454) 220 (4.060) 0.0319 14 (2.167) 15 (2.322) 0.01045
K74 Fibrosis and cirrhosis of the liver 33 (1.753) 60 (1.107) 0.0544 <10 (<1.548) <10 (<1.548) 0
E65-E68 Overweight, obesity, and other hyperalimentation 1245 (66.153) 10 (0.185) 1.963531 <10 (<1.548) <10 (<1.548) 0
1191 Aspirin 778 (41.339) 1632 (30.116) 0.2358213 215 (33.282) 209 (32.353) 0.019782
11289 Warfarin 172 (9.139) 281 (5.185) 0.1537802 36 (5.573) 33 (5.108) 0.020656
8410 Alteplase 140 (7.439) 296 (5.462) 0.08053 33 (5.108) 27 (4.180) 0.044147
1364430 Apixaban 65 (3.454) 95 (1.753) 0.1069543 <10 (<1.548) <10 (<1.548) 0
1114195 Rivaroxaban 34 (1.807) 67 (1.236) 0.0465949 <10 (<1.548) <10 (<1.548) 0
259280 Tenecteplase <10 (<0.531) 16 (0.295) 0.0368061 <10 (<1.548) <10 (<1.548) 0
31500 Intubation, endotracheal, emergency procedure 173 (9.192) 529 (9.762) 0.0194479 33 (5.108) 29 (4.489) 0.028973